Cargando…
Dosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter Study
INTRODUCTION: This multicenter, real-world cohort study aimed to evaluate the effectiveness of early cumulative dose administration and dosing pattern of liposomal irinotecan plus fluorouracil/leucovorin (nal-IRI+5-FU/LV) in patients with gemcitabine-refractory metastatic pancreatic ductal adenocarc...
Autores principales: | Su, Yung-Yeh, Chiang, Nai-Jung, Li, Chung-Pin, Yen, Chia-Jui, Yang, Shih-Hung, Chou, Wen-Chi, Chen, Jen-Shi, Chiu, Tai-Jan, Chen, Yen-Yang, Chuang, Shih-Chang, Bai, Li-Yuan, Chiu, Chang-Fang, Peng, Cheng-Ming, Chan, De-Chuan, Chiu, Sz-Chi, Yang, Yi-Hsin, Shan, Yan-Shen, Chen, Li‐Tzong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256928/ https://www.ncbi.nlm.nih.gov/pubmed/35814374 http://dx.doi.org/10.3389/fonc.2022.800842 |
Ejemplares similares
-
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study
por: Chiu, Tai-Jan, et al.
Publicado: (2021) -
The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort
por: Su, Yung-Yeh, et al.
Publicado: (2020) -
Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer
por: Su, Yung-Yeh, et al.
Publicado: (2023) -
Author Correction: The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort
por: Su, Yung-Yeh, et al.
Publicado: (2020) -
A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors
por: Chiang, Nai-Jung, et al.
Publicado: (2016)